Latest News about NVO
Recent news which mentions NVO
What's Going On Eli Lilly Stock Thursday?
February 08, 2024
From Benzinga
Prediction: 2 Stocks That Could Trounce the Market
February 08, 2024
From Motley Fool
The Skinny On Novo Nordisk: Weight-Loss Meds Make Big Pharma A Big Foe For Food Industry
February 08, 2024
From Benzinga
How Important Are Ozempic and Wegovy to Novo Nordisk's Business?
February 08, 2024
Tickers
NVO
From Motley Fool
Catalent's Bloomington Plant Making Novo Nordisk's Obesity Drug Faces FDA Scrutiny Regarding Drug Manufacturing Concerns
February 07, 2024
From Benzinga
From InvestorPlace
Eli Lilly, Novo Nordisk Could Be First Trillion-Dollar Drug Stocks
February 06, 2024
From InvestorPlace
Why Catalent Stock Soared Today
February 05, 2024
From Motley Fool
Why Novo Nordisk Stock Crushed the Market on Monday
February 05, 2024
From Motley Fool
NVO, LLY or AZN: Which Pharma Stock Is the Best Weight-Loss Investment?
February 05, 2024
From InvestorPlace
Stocks Fall As Traders Dial Back Rate Cut Bets; Dollar, Treasury Yields Rise: What's Driving Markets Monday?
February 05, 2024
From Benzinga
What's Going On With Eli Lilly Stock Today?
February 05, 2024
From Benzinga
Catalent (CTLT) Stock Pops 10% on Sale to Novo Nordisk
February 05, 2024
From InvestorPlace
Ozempic Maker Strikes $11B Deal With Catalent As It Rushes To Meet Massive Weight-Loss Drug Demand
February 05, 2024
From Benzinga
Is Novo Nordisk a Hot Stock to Buy Now After its Spectacular Q4?
February 05, 2024
Tickers
NVO
From Motley Fool
After a 90% Gain, Is It Too Late to Buy Eli Lilly?
February 04, 2024
From Motley Fool
Deep Dive Into Novo Nordisk Stock: Analyst Perspectives (4 Ratings)
February 01, 2024
Tickers
NVO
From Benzinga
The Road to a Trillion: 3 Stocks Next in Line for the Mega Milestone
February 01, 2024
From InvestorPlace
Why Eli Lilly Stock Topped the Market Today
January 31, 2024
From Motley Fool
Take Your Ozempic: Why Late Entry Of Rival Weight-Loss Drugs Won't Floor Novo, Eli Shares
January 31, 2024
From Benzinga
With Bumper $33B Sales, Novo Nordisk Forecasts Double-Digit 2024 Earnings Growth, Boosts Lower Dose Wegovy US Supplies
January 31, 2024
From Benzinga
Novo Nordisk Skyrockets To $506B Valuation Driven By 'Miracle' Drugs Ozempic, Wegovy
January 31, 2024
From Benzinga
Earnings Scheduled For January 31, 2024
January 31, 2024
From Benzinga
Will Novo Nordisk Be a $1 Trillion Company by 2030?
January 30, 2024
From Motley Fool
Eli Lilly Wants to Expand Access to Weight-Loss Treatments In Germany, In Talks With Government
January 29, 2024
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.